Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
NUCKS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
HCK - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FBN3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SVIP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NAA15 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
BLOC1S6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RCN2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LRRC37A2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
NT5DC1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC101929147 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IFNAR1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLC35B4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
USP31 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MRPL47 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FAH - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
EPRS - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NIFK - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FAHD1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
UXS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on